Free & Just: Opposition Letter to Congress for FDA Commissioner Nominee, Dr. Heidi Overton
September 24, 2026
Dear Senators,
We are storytellers and advocates with Free & Just, a network of abortion patients, providers, and experts from across the country, committed to defending reproductive freedom. On behalf of Americans who are suffering in the wake of abortion bans nationwide, we write to express our deep concerns about the nomination of Dr. Heidi Overton to lead the Food and Drug Administration (FDA). Dr. Overton’s anti-abortion record showcases her commitment to banning medication abortion. She celebrated the overturning of Roe v. Wade as "a huge victory for life," dismissed federal legislation protecting abortion rights as "radicalism," and has promoted false claims about the safety of medication abortion that contradict more than two decades of evidence. Her nomination to this role is one of the greatest threats to abortion access and reproductive care since the Dobbs decision and would satisfy anti-abortion extremists who are working relentlessly to ban abortion nationwide — no matter the cost.
The FDA is responsible for determining which medications our nation’s providers can prescribe and under what conditions. That makes this nomination consequential for everyone who relies on medication abortion — including patients who live in states where abortion remains legally protected. Mifepristone is safe, effective, and has been FDA-approved for over twenty years. As of December 2025, medication abortion has accounted for 65% of all US abortions, and one in four clinician-provided abortions were delivered through telehealth. Mifepristone specifically is used to support patients with their reproductive care and is even recommended by the American College of Obstetricians and Gynecologists for miscarriage management. As FDA Commissioner, Heidi Overton would be able to directly impact if, when, and how medication abortion is dispensed across the country and her record clearly demonstrates a willingness to implement the anti-abortion agenda that extremists seek to enact nationally.
Instead of prioritizing the wellbeing of working families, improving public health infrastructure, and lowering health care costs, extremists and anti-abortion lawmakers are pushing dangerous misinformation about the safety of medication abortion that contradicts years of scientific evidence. The American Medical Association (AMA) has stated that serious adverse events occur in fewer than one-third of one percent of patients who take mifepristone, and continuing a pregnancy carries roughly 14 times the risk of death than abortion related complications. Reimposing in-person requirements, the AMA warns, would virtually eliminate telehealth access for rural, low-income, and underserved patients and force doctors to deliver worse care. In February 2026, ACOG led a coalition of 15 medical organizations in defending mifepristone's safety record in court. Yet Overton’s record demonstrates that she will not take any of these facts into serious consideration. She will ignore medical evidence to the detriment of patients' health and safety, exacerbating the already costly impact of abortion bans and the Dobbs decision.
While medication abortion remains available today, we are forced to navigate a complex and ever-changing legal landscape as extremists continue to chip away at access to care. Something that many of us know from experience is that access to medication abortion is equally as important as a patient’s ability to physically obtain it. Before joining the White House, Dr. Overton served as chief policy officer at the America First Policy Institute when the organization called for reinstating in-person dispensing requirements for mifepristone, prohibiting telehealth prescribing, and requiring in-person ultrasounds. The changes Overton seeks to make would create unnecessary barriers for people who cannot easily travel, take time away from work, arrange transportation or childcare, or reach an abortion provider in person. This will inevitably impact marginalized and rural communities disproportionately consistent with what we’ve seen with the overarching impacts of abortion bans since the Dobbs decision.
Overton’s nomination should also be considered within the broader landscape surrounding abortion access right now. Nothing from anti-abortion lawmakers or this administration is happening in isolation. Anti-abortion extremists are pressuring federal agencies like the FDA, Department of Justice, and even the Environmental Protection Agency to abandon years of evidence-based research and ban medication abortion nationwide. While anti-abortion extremists and lawmakers are pressing the FDA to revoke approval of medication abortion and to appoint Overton, Attorney General Todd Blanche is on record committing to "make Dobbs permanent." The FDA commissioner’s decisions can affect patients in every state, including those where abortion remains legally protected. The weaponization of our democratic institutions to ban abortion care is an overstep in government intervention in personal medical decisions and emblematic of how far anti-abortion extremists will go to advance their dangerous agenda.
As the Senate considers Dr. Overton’s nomination, her documented positions on abortion and medication abortion, as well as the potential implications of those positions for FDA policy, warrant close examination alongside the medical evidence and the experiences of the patients and providers who depend on this care. Data from Reproductive Freedom for All and Impact Research find that Americans across the political spectrum are nearly as opposed to a national abortion ban as they are to middle class tax increases and sweeping cuts to Medicaid. Still, anti-abortion extremists continue exploiting federal agencies to launch dangerous attacks on access to reproductive health care.
We urge you to closely scrutinize Dr. Overton’s record during the confirmation process and VOTE NO on advancing her nomination to lead the FDA. The American people deserve an FDA Commissioner who will prioritize science, evidence, and public health over extremist ideology. We call on you to reject this dangerous nomination.
Bianca Allison
Ashley Ammerman
Tabatha Andonian
Anne Angus
Meagan Ankney
Paige Ankney
Lucie Arvallo
Abiodun Badejo
Symone Bailey
Stephanie Baird
Desiree Ballis
Jenna Beckham
Avery Davis Bell
Julian Bell
Amanda Benbow
Caitlin Bernard
Jessica Bernardo
Alenna Beroza
Abby Blum
Megan Bond
Sandee Booth
Ashley Brandt
Marcus Brandt
Casey Britton
Emma Burns
Vilma Caballero
CJ Calica
Amber Calvin
Kate Carson
Erin Case
Samantha Casiano
Rev. Kelli Clement
Elena Colon
Darius Corbett
Carol Cordell
Lucy Couture
margaret couture
Emily Cuarenta
Amanda D’Angelo
Elizabeth (Ellie) Davis
Lane Davis
Lynne Davis
Nancy Davis
Lily deGroot
Kate Dineen
Rachel Dlouhy
Stephanie Dworak
Taylor Edwards
Dawn Ericksen
Oluwadamilola Fakoya
Alliyson Feldmann
Kristyn Fruit
Bethany Galbraith
Kim Jorgensen Gane
Kayleigh Garcia Roffino
Meta Getman
Gabrielle Goodrick
Miranda Graham
Kelly Greeninger
Parker Gresak
Matthew Grocholske
David Hackney
Calla Hales
Laura Hanks
Sarah Hanline
Sarah Hansen
Callie Harper
Deborah Harsha
Amanda Harsin
Jamie Heard
Raven Heck
Mia Henderson
Morgan Homme
Darcy Houchin
Catherine Howard
Amelia Huntsberger
Heather Inman
Charlotte Isenberg
Carmella Jackson
Lynne Jacobs
Nandi Jacobs
Srisha Jayakumar
Ashley Jeanlus
Kaitlyn Kash
Elaine Kaster
Marilyn Kepner
Nicole King
Cassandra Klewicki
Megan Kling
Maria Koegl
Mychael Koegl
Josh Layne
Lacey Layne
Susanna Levin
Gabby Long
Kristin Lyerly
Laurel Marcinkus
Mary Marcinkus
Heather Martell
Julie Martell
Kenya Martin
Tracy McCabe
Lauren Miller
Samantha Montgomery
Sade Moore
Ashwini Murthy
Julie Nye
Ariel Okhah
Sukari Olawumi
Donell Oliver
Lauren Overman
Neha Patil
Dana Pellebon
Grace Perry
Keisha Person
Allie Phillips
Amber Ramirez
Veronica Rand
Megan Raymond
Uma Reddy
Lis Regula
Aubrey Reinhardt
Mia Robbins-Aguilar
Georgia Rodriguez
Marissa Rudd
Melanie Rummel
Lelani Russell
Katie Rutland
Maya Sabharwal
Nikki Sapiro Vinckier
Renee Saxon
Sophie Schott
Kelly Shannon
Laura Shibley
Melanie Shipley
Paulall Sinclair
Jean St. John
Kimberly Stathas
Leila Staton
Blair Stewart
Elisabeth Stovall
Matthew Taft
Danielle Tallafuss
Sara Teichholtz
Debra Teplin
Karen Thompson
Turiya Tomlin-Randall
Lauren Tran
Cori Tucker
Jessica Van Wyen
Anusha Viswanathan
Nicole Walker
Stefanie Wang
Elise Warren
Malachi White
Shanette Williams
Kathryn Williamson
Mimi Zieman
Elizabeth Zordani
Amanda Zurawski